×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Hair growth

Published on .

Seeking new ways to market its hair growth product Rogaine, Pharmacia & Upjohn, Kalamazoo, Mich., is near full Food & Drug Administration approval for a new double-strength 5% minoxidil prescription version. With $50 million in support via Grey Advertising, New York, through October for the over-the-counter version and a history of heavy media spending behind the brand, direct-to-consumer ads are likely. Pharmacia seeks to distinguish the brand now as it lost its patent for the OTC version last April when FDA chose not to extend protection. An FDA advisory committee gave initial approval for the new prescription version in December.

Copyright January 1997, Crain Communications Inc.

In this article:
Most Popular